Graduate Diploma of Education (Applied Science), 1976
Professor Pamela Russell has led an extraordinary career in medical research, making a significant impact in the field of oncology. From 1977 to 1979, Pamela worked and studied at the Canberra College of Advanced Education (now the University of Canberra) in the School of Applied Science, establishing new courses in haematology and medical microbiology. Following this, Pamela returned to the Kolling Institute of Medical Research before helping to found the Urological Cancer Research Centre at Royal Prince Alfred Hospital. Pamela was appointed Director of the Oncology Research Centre at the Prince of Wales Hospital from 1992 to 2009 while also holding a conjoint chair in medicine at the University of New South Wales.
In 2009 and 2010, Pamela was made a Professor of Medicine in UNSW's Prince of Wales Clinical School. Pamela's most recent full-time appointment is the Head of Biomedical Imaging and Prostate Cancer Models at the Australian Prostate Cancer Research Centre in the Institute of Health and Biomedical Innovation at the Queensland University of Technology.
Internationally recognized for her work on bladder and prostate cancer, career highlights include production of monoclonal antibodies against cancer and targeted nanoparticle imaging to improve diagnosis and staging of prostate cancer. She has written over 200 papers for international journals, numerous books, chapters and conference papers, and holds 2 international and several provisional patents. Pam collaborates widely within Australia and overseas, and to date has raised over $37 million in competitive grants and industry support, mentored 31 post-doctoral scholars, and helped to run 4 international conferences.
In addition to her ground-breaking studies, Pamela has helped to establish organisations which have had a profound impact on the oncology world, including the Prostate Cancer Foundation of Australia, the Australasian Genitourinary Oncology Group and the Australasian Urological and Prostate Cancer Clinical Trials Group. She is a member of the Australian Prostate Cancer Collaboration and has been involved with the Global Action Plan for Movember, bringing together expert clinicians and researchers around the world to make breakthroughs for treating advanced prostate cancer.For
her incredible work, Pam was made a member of the Order of Australia in 2005, and received an Honorary Life Membership of the Prostate Cancer Foundation of Australia in 2006, an Honorary Life Membership of the Australasian Gene Therapy Society in 2009, the inaugural award for Prostate Cancer Researcher of the Year in 2010, and made Fellow of the Australian Academy of Health and Medical Sciences in 2015.